LncRNA H19 functions as an oncogene in numerous cancer types, including gastric (99), colorectal (100), pancreatic (101) and BC, to the extent that plasma H19 has been proposed as a diagnostic and prognostic biomarker for BC (47, 102). Here, H19 is linked to breast cancer.